NYSE · CIK 0001076378
CX CEMEX SAB DE CV
Insider trading from SEC Form 4. Last filing 12 d ago. Close $9.56 on Oct 9, 2026, +6% from the 52-week low and -29% from the high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at CEMEX SAB DE CV, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | Cobian Mauricio Doehner EVP Corporate Affairs sell | $8.9M 927,900 shares | -61% | - | |
| 40Moderate | Lozano Rogelio Zambrano director buy | $6.9M 400,800 shares | +4% | - |
Congressional trades
1 trade in CX disclosed by members of Congress under the STOCK Act. All congressional trades.
- Sheri BiggsHouse · R-SC · last Oct 5, 20250 bought
1 sold
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Sheri Biggs House · R-SC | Sale | CX Cemex, S.A.B. de C.V. Sponsored ADR | $1,001 to $15k | Mar 18, 2025 / Oct 5, 2025 201 days after the trade | Clerk |
Transactions
The last 2 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Cobian Mauricio Doehner EVP Corporate Affairs | SOpen-market sale Ordinary Participation Certificates (CEMEX.CPO) | -927,900 | $9.57 | $8.9M | 584,930 | 12 d ago |
| Sep 25, 2026 | Lozano Rogelio Zambrano director | POpen-market purchase Ordinary Participation Certificates (CEMEX.CPO)indirect: Spouse | +400,800 | $17.28 | $6.9M | 10,000,000 | 17 d ago |
Insiders
Everyone who has filed a Form 4 here.
- Cobian Mauricio DoehnerEVP Corporate Affairs
- Lozano Rogelio Zambranodirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.